---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-031976"
form_type: "8-K/A"
ticker: "ABVC"
cik: "0001173313"
company_name: "ABVC BIOPHARMA, INC."
filed_at: "2022-06-09T23:59:59+00:00"
generated_at: "2026-06-25T03:03:09.253052+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# ABVC BioPharma appoints Hsin-Hui Miao to board after director's passing

## Summary
- Director Dr. Shin-Yu Miao passed away; vacancy filled by his sister Hsin-Hui Miao.
- Ms. Miao appointed on June 4, 2022, effective immediately, serving until next annual meeting.
- She will join Audit, Corporate Governance & Nomination, and Compensation committees.
- Ms. Miao receives $3,500 monthly compensation, same as other directors.
- No related-party transactions above $120,000 or 1% of assets in last two years.

## SEC filing metadata
- accession: 0001213900-22-031976
- form_type: 8-K/A
- ticker: ABVC
- cik: 0001173313
- company_name: ABVC BIOPHARMA, INC.
- filed_at: 2022-06-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1173313/000121390022031976/0001213900-22-031976-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1173313/000121390022031976/ea161330-8ka1_abvc.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-031976
- JSON: https://secwatch.observer/filing/0001213900-22-031976.json
- Plain text: https://secwatch.observer/filing/0001213900-22-031976.txt

## Key facts
- Executive change
  Hsin-Hui Miao was appointed as Director at ABVC BIOPHARMA, INC..
  - Action: appointed
  - Role: Director
  source text: the board appointed Ms. Hsin-Hui Miao to fill the vacancy created by Dr. Miao’s passing.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1173313/000121390022031976/0001213900-22-031976-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.